)
)
Nanopore Sequencing to Understand and Diagnose Brain Tumours
Brain tumours are highly heterogeneous and increasingly defined by their molecular features, but conventional diagnostic pathways can take weeks to provide a complete molecular profile. We have developed and clinically piloted nanopore-based sequencing workflows that deliver real-time intraoperative classification using methylation, copy number, and structural variant profiles—achieving high concordance with gold-standard diagnostics in under 24 hours. This talk will explore how rapid sequencing can transform surgical decision-making, streamline trial enrolment, and pave the way for integrated, multimodal diagnosis.
